Eton Pharmaceuticals (ETON) Price to Sales (2019 - 2026)

Eton Pharmaceuticals has disclosed Price to Sales across 8 years of filings, most recently posting 27.24 for Q2 2026.

• In Q2 2026, Price to Sales rose 34.94% year-over-year to 27.24; the TTM figure through Jun 2026 stood at 10.21 (up 55.52% YoY), while the FY2025 annual figure was 5.72, down 37.27% from the prior year.
• Price to Sales came in at 27.24 for Q2 2026 at Eton Pharmaceuticals, up from 21.49 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 49.34 in Q1 2022 to a low of 7.44 in Q2 2023.
• Average Price to Sales over 5 years is 19.18, with a median of 16.5 recorded in 2022.
• The largest YoY upside for Price to Sales was 227.56% in 2022 against a maximum downside of 89.69% in 2022.
• Over 5 years, Price to Sales stood at 8.41 in 2022, then jumped by 82.87% to 15.39 in 2023, then jumped by 98.54% to 30.55 in 2024, then fell by 29.64% to 21.49 in 2025, then increased by 26.77% to 27.24 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 27.24 in Q2 2026, 21.49 in Q4 2025, and 25.95 in Q3 2025.